Kiran Gajurel

Dr. Kiran Gajurel


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
EBEsther Benamu
Esther Benamu
KGKiran Gajurel
Kiran Gajurel
JAJill N Anderson
Jill N Anderson
TLTullia Lieb
Tullia Lieb
CGCarlos A Gomez
Carlos A Gomez
SDStan Deresinski
Stan Deresinski
Background: Standard testing fails to identify a pathogen in most patients with febrile neutropenia (FN). We evaluated the ability of the Karius microbial cell-free DNA sequencing test (KT) to identify infectious etiologies of FN and its impact on antimicrobial management. Methods: This prospective study (ClinicalTrials.gov; NCT02912117) enrolled and analyzed 55 patients with FN. Up to 5 blood samples were collected per subject within 24 hours of fever onset (T1) and every 2 to 3 days. KT results were compared with blood culture (BC) and standard microbiological testing (SMT) results. Results: Positive agreement was defined as KT identification of ≥1 isolate also detected by BC. At T1, positive and negative agreement were 90% (9/10) and 31% (14/45), respectively; 61% of KT detections were polymicrobial. Clinical adjudication by 3 independent infectious diseases specialists categorized Karius results as: unlikely to cause FN (N = 0); definite (N = 12): KT identified ≥1 organism also found by SMT within 7 days; probable (N = 19): KT result was compatible with a clinical diagnosis; possible (N = 10): KT result was consistent with infection but not considered a common cause of FN. Definite, probable, and possible cases were deemed true positives. Following adjudication, KT sensitivity and specificity were 85% (41/48) and 100% (14/14), respectively. Calculated time to diagnosis was generally shorter with KT (87%). Adjudicators determined real-time KT results could have allowed early optimization of antimicrobials in 47% of patients, by addition of antibacterials (20%) (mostly against anaerobes [12.7%]), antivirals (14.5%), and/or antifungals (3.6%); and antimicrobial narrowing in 27.3% of cases. Clinical Trials Registration: NCT02912117 Conclusion: KT shows promise in the diagnosis and treatment optimization of FN.

5 September 2017 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
KGKiran Gajurel
Kiran Gajurel
RDReshika Dhakal
Reshika Dhakal
SDStan Deresinski
Stan Deresinski

9 December 2016 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
KGKiran Gajurel
Kiran Gajurel
RDReshika Dhakal
Reshika Dhakal
SDStan Deresinski
Stan Deresinski

9 June 2016 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
KGKiran Gajurel
Kiran Gajurel
CGC.A. Gomez
C.A. Gomez
RDR. Dhakal
R. Dhakal
HVH. Vogel
H. Vogel
JMJ.G. Montoya
J.G. Montoya

6 December 2021 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
PDF file
KGKiran Gajurel
Kiran Gajurel
SDStan Deresinski
Stan Deresinski
Rituals are an integral part of human life but a wide range of rituals (both religious and non-religious), from self-flagellation to blood brotherhood to ritual sprinkling of holy water, have been associated with transmission of infections. These infections include angiostrongyliasis, anthrax, brucellosis, cholera, COVID-19, cutaneous larva migrans, Ebola, hepatitis viruses, herpes simplex virus, HIV, human T-cell leukemia virus (HTLV), kuru, Mycobacterium bovis, Naegleria fowleri meningoencephalitis, orf, rift valley fever, and sporotrichosis. Education and community engagement are important cornerstones in mitigating infectious risks associated with rituals.

15 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
KGKiran Gajurel
Kiran Gajurel
RDReshika Dhakal
Reshika Dhakal
SDStan Deresinski
Stan Deresinski
The incidence of arbovirus infections has increased in recent decades. Other than dengue, chikungunya, and West Nile viruses, the data on arbovirus in solid organ transplant (SOT) are limited to case reports, and infections in renal transplant recipients account for most of the reported cases. Dengue and West Nile infections seem to be more severe with higher mortality in SOT patients than in the general population. Acute kidney injury is more frequent in patients with dengue and chikungunya although persistent arthralgia with the latter is less frequent. There is no clear relationship between arboviral infection and acute cellular rejection. Pre-transplant screening of donors should be implemented during increased arboviral activity but, despite donor screening and negative donor nucleic acid amplification test (NAT), donor derived infection can occur. NAT may be transiently positive. IgM tests lack specificity, and neutralizing antibody assays are more specific but not readily available. Other tests, such as immunohistochemistry, antigen tests, PCR, metagenomic assays, and viral culture, can also be performed. There are a few vaccines available against some arboviruses, but live vaccines should be avoided. Treatment is largely supportive. More data on arboviral infection in SOT are needed to understand its epidemiology and clinical course.